MDERMAJET by SUPIONM —
a needle-free aesthetic device reflecting our hardware engineering and technology development expertise.
The technology development story behind MDERMALAB by SUPIONM
At SUPIONM, product development is about more than creating a new design. It is about turning technical ideas into tangible hardware, refining them through professional collaboration, and bringing them into real-world business environments.
MDERMAJET is one example of this approach. Developed as part of our MDERMALAB technology portfolio, it reflects our experience in hardware engineering, prototype development, and international market expansion
Selected for a Government-Supported Open Lab Program
In 2025, SUPIONM was selected to participate in the Korea University Guro Hospital Open Lab program, part of an initiative supported by South Korea’s Ministry of Health and Welfare.
The program gave us an opportunity to advance our hardware development project through access to collaborative resources and professional expertise.
Our work focused on a needle-free liquid delivery concept, with particular attention to the technical structure and engineering considerations required to develop a functional prototype.
Participation in the program marked an important stage in bringing our hardware concept closer to a finished product.
From Technical Consultation to Hardware Prototype
During the development process, we worked on pressure-control components, internal circuitry, and mechanical design.
We also conducted professional consultations on device design and potential research applications.
These discussions included early-stage research considerations related to skin conditions, wound management, and needle-free technology.
By combining our engineering work with expert consultation, we refined the technical direction of the project and completed an initial hardware prototype.
The result was more than a concept presented on paper. It was a physical development milestone that gave us a stronger foundation for further product refinement and commercialization activities.
SUPIONM Featured in Hospital Newspaper | 2025 Open Lab Orientation
Hospital Newspaper reported on the 2025 Korea University Guro Hospital Open Lab orientation, highlighting collaboration among participating companies, including SUPIONM.
Source: Hospital Newspaper | June 17, 2025
Read the Original Article →https://khanews.com/news/articleView.html?idxno=233683
SUPIONM Mentioned in Medical Observer | 2025 Open Lab Marketing Workshop
Medical Observer covered a marketing workshop for companies participating in the Korea University Guro Hospital Open Lab program, including SUPIONM.
Source: Medical Observer | August 27, 2025
Read the Original Article →https://www.monews.co.kr/news/articleView.html?idxno=405944
MDERMALAB: The Technology Behind MDERMAJET
As the company responsible for technology development behind M DERMA LAB, SUPIONM has expanded its work from skin care formulations into hardware engineering.
MDERMA JET reflects this combination of technical development and brand expertise.
Our development process has involved exploring hardware structures, refining device components, and considering how product concepts can be translated into practical solutions.
This hands-on engineering experience is an important part of what distinguishes the M DERMA LAB technology portfolio.
MDERMA JET Professional Training & Demonstration
- Hands-on device demonstration and professional training conducted by the SUPIONM education team in Korea, sharing practical product knowledge and device operation experience.
Two Korean Patent Applications Reflecting Original Hardware Development
SUPIONM | Two Korean Patent Applications, 2025
Official patent filing documents for two Korean patent applications covering a needle-free aesthetic liquid delivery device and a method of using the device.
M Derma AirJet | FDA Registration Documentation, 2026
Documentation relating to the U.S. FDA registration of M Derma AirJet.
SUPIONM | CE Declaration & Research Award
CE conformity documentation and the 2025 Outstanding Research Poster Award for MDERMA JET and MDERMA LAB research.
SUPIONM | Technology, Patents & Global Development
MDERMAJET patent applications, FDA registration-related documentation, CE declaration, a research poster award, and MDERMALAB skin booster development by SUPIO.
In 2025, SUPIONM filed two Korean patent applications based on technical concepts developed through our hardware research and engineering work.
The applications relate to our work on non-invasive liquid delivery technology and device design.
For business partners evaluating M DERMA JET, these filings provide a documented connection between the product’s technical development and our efforts to protect original engineering concepts.
Rather than relying solely on a product concept or visual design, M DERMA JET has a development history that includes prototype engineering, professional consultation, and formal patent filings.
Together, these milestones help demonstrate the technical work behind the brand and provide additional context for partners considering our hardware products.
In 2025, SUPIONM advanced its M DERMA JET technology through hardware research, engineering, and intellectual property development.
Selected for support through the Narae IP program, administered by the Busan Intellectual Property Center under the Korea Invention Promotion Association, SUPIONM filed two Korean patent applications covering a needle-free liquid delivery device and its method of use.
Our technology development activities also include U.S. FDA registration-related documentation and an EC Declaration of Conformity, reflecting our preparations for international markets.
In addition, research involving M DERMA JET and M DERMA LAB, with participation from Korea University Guro Hospital and SUPIONM, received an Outstanding Poster Award at the 2025 Spring Conference of the Korean Society of Radiological Science.
Together, these milestones highlight SUPIONM’s continued investment in original hardware technology, intellectual property, academic research, and global business development.
Alongside MDERMAJET hardware technology development, SUPIO has developed and manufactured the MDERMALAB skin booster line, advancing Korean skin booster technology and aesthetic technology together.
This integrated approach highlights SUPIONM’s expertise in aesthetic device engineering and professional skincare product development, supporting international B2B partnerships and OEM manufacturing opportunities.
From Korea to International Markets
MDERMA JET has been introduced through business activities and professional education in markets including Vietnam, Australia, the United States, and Taiwan.
We have worked with international partners to present our technology, share product knowledge, and conduct professional training.
In Korea, our products have also been introduced through hospital-related distribution channels.
These experiences have helped us build relationships across different markets and gain practical insight into international product introduction and distribution.
Expanding Our Aesthetic & Wellness Technology Portfolio
Building on the engineering expertise developed through M DERMA JET, SUPIONM continues to expand its technology portfolio beyond needle-free liquid delivery systems.
Our development activities extend to ultra-high-frequency microwave technology, plasma-based systems including SONOPLASMA, and innovative beauty and wellness devices.
At the same time, SUPIO develops and manufactures professional skin booster products, including the M DERMA LAB line, bringing together Korean skin booster technology and advanced aesthetic solutions.
This combination of hardware engineering and skincare formulation expertise allows SUPIONM to offer international partners a broader range of product development and business opportunities.
SUPIONM | Advanced Aesthetic Energy & Plasma Technology
Advanced aesthetic devices featuring microwave-based energy therapy and plasma technology, expanding SUPIONM’s professional beauty and wellness portfolio.
SUPIONM | Advanced RF, EMS & Body Care Devices
Professional aesthetic and home care devices featuring radiofrequency (RF), EMS, cavitation, deep-heat technology, and vacuum suction. Our REBODY and multifunctional beauty devices offer versatile solutions for facial, body, and wellness care.
SUPIO | Professional Korean Skin Booster Collection
Developed and manufactured by SUPIO, our professional skin booster collection features a diverse range of formulations, including Exosome, PDRN, Hyaluronic Acid (HA), Collagen, PLLA, NAD+, Lifting, and Hair & Growth Booster concepts.
Combining Korean skincare formulation expertise with professional aesthetic product development, SUPIO provides innovative skin booster solutions for international beauty businesses, distributors, and OEM partners.
SUPIONM | Korean Aesthetic Technology & Global Business
From initial engineering concepts and hardware prototypes to patent applications, research recognition, and international market development, MDERMAJET represents SUPIONM’s commitment to continuous innovation.
Together with the M DERMA LAB skin booster line developed and manufactured by SUPIO, our technology portfolio demonstrates our capabilities across both aesthetic hardware and professional skincare.
With experience in product development, manufacturing, professional education, and international business, SUPIONM works with global partners seeking Korean aesthetic technologies, skin booster products, and OEM manufacturing solutions.
We welcome international distributors, beauty and wellness businesses, and OEM partners to explore new opportunities with SUPIONM.
Explore Our Products
Explore SUPIO Skin Boosters →
Discover Beauty & Wellness Devices →
Global Business & Partnership Inquiries →
Product and business inquiries
www.mdermalab.us
info@supionm.com
Product information: Technical consultations and development activities described here are part of SUPIONM’s research and product development history. Patent applications are pending filings, not granted patents. Product classification, registration, intended use, and distribution requirements are determined separately for each model and market.